These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9576978)

  • 21. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts.
    Kameda T; Mano H; Yuasa T; Mori Y; Miyazawa K; Shiokawa M; Nakamaru Y; Hiroi E; Hiura K; Kameda A; Yang NN; Hakeda Y; Kumegawa M
    J Exp Med; 1997 Aug; 186(4):489-95. PubMed ID: 9254647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Casodex (a nonsteroidal antiandrogen) reduces cancellous, endosteal, and periosteal bone formation in estrogen-replete female rats.
    Lea C; Kendall N; Flanagan AM
    Calcif Tissue Int; 1996 Apr; 58(4):268-72. PubMed ID: 8661959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of mechanical stress/strain and estrogen on cancellous bone structure predicted by fuzzy decision.
    Luo ZP; Zhang L; Turner RT; An KN
    IEEE Trans Biomed Eng; 2000 Mar; 47(3):344-51. PubMed ID: 10743776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the selective estrogen receptor modulator ospemifene on bone in rats.
    Kangas L; Härkönen P; Väänänen K; Peng Z
    Horm Metab Res; 2014 Jan; 46(1):27-35. PubMed ID: 24108389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status.
    Moon LY; Wakley GK; Turner RT
    Endocrinology; 1991 Sep; 129(3):1568-74. PubMed ID: 1874188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.
    Iwamoto J; Seki A; Takeda T; Sato Y; Yamada H; Shen CL; Yeh JK
    Exp Anim; 2006 Jul; 55(4):349-55. PubMed ID: 16880682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An estrogen receptor basis for raloxifene action in bone.
    Bryant HU; Glasebrook AL; Yang NN; Sato M
    J Steroid Biochem Mol Biol; 1999; 69(1-6):37-44. PubMed ID: 10418979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen and bone. Marshall R. Urist's contributions.
    Gordan GS
    Clin Orthop Relat Res; 1985 Nov; (200):174-80. PubMed ID: 3905109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental (tamoxifen-induced) manipulation of female reproduction in zebra finches (Taeniopygia guttata).
    Williams TD
    Physiol Biochem Zool; 2000; 73(5):566-73. PubMed ID: 11073791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Raloxifene inhibits bone turnover and prevents further cancellous bone loss in adult ovariectomized rats with established osteopenia.
    Evans GL; Bryant HU; Magee DE; Turner RT
    Endocrinology; 1996 Oct; 137(10):4139-44. PubMed ID: 8828469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The minimum effective dose of estrogen for prevention of postmenopausal bone loss.
    Lindsay R; Hart DM; Clark DM
    Obstet Gynecol; 1984 Jun; 63(6):759-63. PubMed ID: 6374537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estrogen receptors α and β have different gender-dependent effects on the adaptive responses to load bearing in cancellous and cortical bone.
    Saxon LK; Galea G; Meakin L; Price J; Lanyon LE
    Endocrinology; 2012 May; 153(5):2254-66. PubMed ID: 22416084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physical activity in the androgen receptor knockout mouse: evidence for reversal of androgen deficiency on cancellous bone.
    Ophoff J; Callewaert F; Venken K; De Gendt K; Ohlsson C; Gayan-Ramirez G; Decramer M; Boonen S; Bouillon R; Verhoeven G; Vanderschueren D
    Biochem Biophys Res Commun; 2009 Jan; 378(1):139-44. PubMed ID: 19013130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Growth hormone increases cortical and cancellous bone mass in young growing rats with glucocorticoid-induced osteopenia.
    Ortoft G; Andreassen TT; Oxlund H
    J Bone Miner Res; 1999 May; 14(5):710-21. PubMed ID: 10320519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of the effects of the aromatase inhibitors anastrozole and letrozole on bone metabolism in postmenopausal women with estrogen receptor-positive breast cancer.
    McCaig FM; Renshaw L; Williams L; Young O; Murray J; Macaskill EJ; McHugh M; Hannon R; Dixon JM
    Breast Cancer Res Treat; 2010 Feb; 119(3):643-51. PubMed ID: 19941160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure.
    Tang LY; Jee WS; Ke HZ; Kimmel DB
    J Bone Miner Res; 1992 Sep; 7(9):1093-104. PubMed ID: 1414502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 17 beta-estradiol stimulates cancellous bone formation in female rats.
    Chow JW; Lean JM; Chambers TJ
    Endocrinology; 1992 May; 130(5):3025-32. PubMed ID: 1572310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
    Evans G; Bryant HU; Magee D; Sato M; Turner RT
    Endocrinology; 1994 May; 134(5):2283-8. PubMed ID: 8156931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LY353381 x HCl: an improved benzothiophene analog with bone efficacy complementary to parathyroid hormone-(1-34).
    Sato M; Zeng GQ; Rowley E; Turner CH
    Endocrinology; 1998 Nov; 139(11):4642-51. PubMed ID: 9794476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of neonatal exposure to diethylstilbestrol and tamoxifen on pelvis and femur in male mice.
    Fukazawa Y; Nobata S; Katoh M; Tanaka M; Kobayashi S; Ohta Y; Hayashi Y; Iguchi T
    Anat Rec; 1996 Mar; 244(3):416-22. PubMed ID: 8742705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.